by Maria Zannes | Feb 16, 2021 | Events
Dr. David Elzi will present the poster “Meso-tetra (4-carboMeso-tetra (4-carboxyphenyl) porphyrin (TCPP) is taken up in cancer cells by the CD320 receptor” at the International Conference on Porphyrins and Phthalocyanines (ICPP) ICPP-11 virtual from June 26 through...
by Maria Zannes | Feb 5, 2021 | Events
Dr. David Elzi will present his poster “Simultaneous knockdown of CD320 and LRP2 receptors is selectively toxic to cancer cells but not normal cells” at the American Association of Cancer Research (AACR) Virtual Annual Meeting 2021, April 10-15 and May 17-21. Session:...
by Maria Zannes | Jan 27, 2021 | Events
Chief Medical & Science Officer Vivienne Rebel, MD, PhD, will present her poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” on January 28th through January 31st, 2021, at the International...
by Maria Zannes | Nov 10, 2020 | Events, Press Releases
Nov. 10, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, today announced that its poster “Meso-tetra (4-carboxyphenyl) porphyrin (TCPP) is incorporated into cancer cells by the CD320 receptor and clathrin mediated endocytosis” will...
by Maria Zannes | Oct 22, 2020 | Events, Press Releases
OCTOBER 22, 2020 (San Antonio, TX) bioAffinity Technologies, a privately held biotech company, announced its poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” has been accepted for presentation...
by Maria Zannes | Sep 24, 2020 | Articles, Events, News
SEPTEMBER 24, 2020 Originally published in Medical Design & Outsourcing by Sean Whooley. Maria Zannes and her company BioAffinity Technologies are seeking to up the game on lung cancer detection. Here’s how. Maria Zannes’ path to a leading role in the...
